These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 22354032)
1. Involvement of host cell integrin α2 in Cryptosporidium parvum infection. Zhang H; Guo F; Zhu G Infect Immun; 2012 May; 80(5):1753-8. PubMed ID: 22354032 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the host ranges and antigenicity of Cryptosporidium parvum and Cryptosporidium wrairi from guinea pigs. Chrisp CE; Suckow MA; Fayer R; Arrowood MJ; Healey MC; Sterling CR J Protozool; 1992; 39(3):406-9. PubMed ID: 1386385 [TBL] [Abstract][Full Text] [Related]
3. Cryptosporidium parvum Elongation Factor 1α Participates in the Formation of Base Structure at the Infection Site During Invasion. Yu X; Guo F; Mouneimne RB; Zhu G J Infect Dis; 2020 May; 221(11):1816-1825. PubMed ID: 31872225 [TBL] [Abstract][Full Text] [Related]
4. Molecular targets for detection and immunotherapy in Cryptosporidium parvum. Boulter-Bitzer JI; Lee H; Trevors JT Biotechnol Adv; 2007; 25(1):13-44. PubMed ID: 17055210 [TBL] [Abstract][Full Text] [Related]
5. In vitro inhibition of Cryptosporidium parvum infection by human monoclonal antibodies. Elliot BC; Wisnewski AV; Johnson J; Fenwick-Smith D; Wiest P; Hamer D; Kresina T; Flanigan TP Infect Immun; 1997 Sep; 65(9):3933-5. PubMed ID: 9284173 [TBL] [Abstract][Full Text] [Related]
6. Identification of host protein ENO1 (alpha-enolase) interacting with Cryptosporidium parvum sporozoite surface protein, Cpgp40. Wang Y; Li N; Liang G; Wang L; Zhang X; Cui Z; Li X; Zhang S; Zhang L Parasit Vectors; 2024 Mar; 17(1):146. PubMed ID: 38504274 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Cryptosporidium parvum and Cryptosporidium wrairi by reactivity with monoclonal antibodies and ability to infect severe combined immunodeficient mice. Chrisp CE; Mason P; Perryman LE Infect Immun; 1995 Jan; 63(1):360-2. PubMed ID: 7806379 [TBL] [Abstract][Full Text] [Related]
11. Hyperimmune bovine colostrum specific for recombinant Cryptosporidium parvum antigen confers partial protection against cryptosporidiosis in immunosuppressed adult mice. Jenkins MC; O'Brien C; Trout J; Guidry A; Fayer R Vaccine; 1999 May; 17(19):2453-60. PubMed ID: 10392628 [TBL] [Abstract][Full Text] [Related]
12. Innate and cell-mediated immune responses to Cryptosporidium parvum. Theodos CM Adv Parasitol; 1998; 40():87-119. PubMed ID: 9554071 [TBL] [Abstract][Full Text] [Related]
13. Comparative proteomics reveals Cryptosporidium parvum manipulation of the host cell molecular expression and immune response. Li T; Liu H; Jiang N; Wang Y; Wang Y; Zhang J; Shen Y; Cao J PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009949. PubMed ID: 34818332 [TBL] [Abstract][Full Text] [Related]
15. Infection with anthroponotic Cryptosporidium parvum does not fully protect the host against a subsequent challenge with C. hominis. Sheoran AS; Pina-Mimbela R; Keleher A; Girouard D; Tzipori S Microbes Infect; 2018 Apr; 20(4):267-270. PubMed ID: 29357304 [TBL] [Abstract][Full Text] [Related]
16. Targeted disruption of CSL ligand-host cell receptor interaction in treatment of Cryptosporidium parvum infection. Riggs MW; Schaefer DA; Kapil SJ; Barley-Maloney L; Perryman LE; McNeil MR J Eukaryot Microbiol; 2001; Suppl():44S-46S. PubMed ID: 11906075 [No Abstract] [Full Text] [Related]
17. Role of immunoglobulin A monoclonal antibodies against P23 in controlling murine Cryptosporidium parvum infection. Enriquez FJ; Riggs MW Infect Immun; 1998 Sep; 66(9):4469-73. PubMed ID: 9712802 [TBL] [Abstract][Full Text] [Related]
18. Human monoclonal antibodies against Cryptosporidium parvum generated by hypo-osmolar electrofusion. Flanigan TP; Wisnewski A; Wiest PM; Johnson J; Tzipori S; Hamer D; Lam N; Kresina TF Trans Assoc Am Physicians; 1993; 106():86-90. PubMed ID: 8036749 [No Abstract] [Full Text] [Related]